Viewing Study NCT02874261



Ignite Creation Date: 2024-05-06 @ 8:58 AM
Last Modification Date: 2024-10-26 @ 12:08 PM
Study NCT ID: NCT02874261
Status: COMPLETED
Last Update Posted: 2017-10-02
First Post: 2016-08-17

Brief Title: Whole Body Periodic Acceleration on Activity and Sleep In Parkinsons Disease
Sponsor: New York Institute of Technology
Organization: New York Institute of Technology

Study Overview

Official Title: Effects of Whole Body Periodic Acceleration on Activity and Sleep In Parkinsons Disease
Status: COMPLETED
Status Verified Date: 2017-09
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Whole-body periodic acceleration WBPA is a new non-invasive and promising therapy for a diverse and growing list of disorders including cardiovascular disease During WBPA patients lie in the supine position on a bed that is capable of translating back and forth parallel to the ground along the head-to-foot axis of the patient Thus this treatment is best described as a form of passive exercise The frequency of the translation up to 180 cyclesminute cpm as well as the distance traveled 2-24mm by the bed can be adjusted by the patient or health care professional

The science behind the therapeutic effects of WBPA still remains largely unknown

The investigators are observing how WBPA may impact on sleep and activity in individuals with Parkinsons disease
Detailed Description: Sleep disturbances are common in individuals with Parkinsons Disease Whole-body periodic acceleration WBPA is a new non-invasive and promising therapy for a diverse and growing list of disorders During WBPA patients lie in the supine position on a bed that is capable of translating back and forth parallel to the ground along the head-to-foot axis of the patient Thus this treatment is best described as a form of passive exercise WBPA has been shown in previous studies to increase nitric oxide Increased levels of nitric oxide have been shown to improve sleep patterns in other populations The current pilot study will investigate how WBPA will impact upon sleep disturbances in subjects with Parkinsons disease who suffer from abnormal sleep patterns The investigators will record sleep patterns and activity levels using a Jawbone U3 activity monitor

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None